HOME › Research Insight › New Product Launches Was the Key Growth Strategy in the Protein Characterization and Identification Market between 2011 and 2014
New Product Launches Was the Key Growth Strategy in the Protein Characterization and Identification Market between 2011 and 2014
Protein characterization and identification is increasingly being used in all fields of biopharmaceutical production, life science research, including drug discovery, diagnostics, immunology, and oncology. Protein characterization and identification is the characterization of protein, based on protein size, shape, sequence, and physiochemical properties such as molecular weight, relative hydrophobicity, isoelectric point, and spectral analysis. The growth of the protein characterization and identification market will be driven by increased government funding for protein characterization and identification research, growing proteomics and biologics markets, technological advancements, and increased research activities related to drug discovery.
The major players in the protein characterization and identification market include Agilent Technologies (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corp. (U.S.), Danaher Corp. (U.S.), GE Healthcare (U.K.), Perkin Elmer (U.S.), Shimadzu Corp. (Japan), Sigma-Aldrich Corp. (U.S.), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S).
The global protein characterization and identification market is highly evolved, with multiple different product segments. An analysis of market developments between 2011 and 2014 revealed that new product launches was the most important growth strategy employed by market leaders in this period. This strategy was adopted by most players in this market, except Bio-Rad Laboratories, Inc. (U.S.) and GE Healthcare (U.K.).
The other important growth strategies adopted by players in this market were agreements and collaborations and mergers and acquisitions. The strategies were adopted by the players in this market to gain immediate technological competency and widen their geographic presence. These strategies were adopted by all the players in this market except GE Healthcare (U.K.), Perkin Elmer (U.S.), Shimadzu Corp. (Japan), that did not enter into any agreements, partnership, and collaborations or mergers between 2011 and 2014.
Protein Characterization and Identification Market by Instruments (Chromatography, Electrophoresis, Mass Spectroscopy), Consumables & Services, Application (Clinical Diagnosis, Drug Discovery & Development), & by End Users - Global Forecast to 2019
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252